BMY
Bristol-Myers Squibb Company
NYSE: BMY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$60.59
+5.21% today
Updated 2026-04-30
Market cap
$123.71B
P/E ratio
17.51
P/S ratio
2.57x
EPS (TTM)
$3.46
Dividend yield
4.32%
52W range
$41 – $62
Volume
12.1M
Bristol-Myers Squibb Company (BMY) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $25.57B | $26.17B | $29.49B | $31.01B | $31.08B | $32.97B | $35.90B | $38.59B | $33.75B | $31.75B | $33.71B | $33.55B | $34.99B | $129.94B | $118.48B | $109.31B | $96.82B | $95.16B | $92.60B | $90.04B |
| Cash & equivalents | $2.02B | $1.80B | $7.98B | $7.68B | $5.03B | $5.78B | $1.66B | $3.59B | $5.57B | $2.38B | $4.24B | $5.42B | $6.91B | $12.35B | $14.55B | $13.98B | $9.12B | $11.46B | $10.35B | $10.21B |
| Current assets | $10.30B | $10.35B | $14.70B | $13.96B | $13.27B | $15.32B | $9.52B | $18.92B | $14.61B | $10.41B | $13.70B | $14.85B | $17.72B | $29.35B | $30.19B | $33.26B | $27.27B | $31.77B | $29.78B | $29.39B |
| Total liabilities | $15.58B | $15.61B | $17.28B | $16.22B | $15.44B | $17.10B | $22.26B | $23.36B | $18.77B | $17.32B | $17.36B | $21.70B | $20.86B | $78.25B | $80.60B | $73.31B | $65.70B | $65.67B | $76.22B | $71.53B |
| Current liabilities | $6.50B | $8.64B | $6.71B | $6.31B | $6.74B | $7.78B | $8.28B | $12.44B | $8.46B | $8.02B | $8.84B | $9.56B | $10.65B | $18.30B | $19.08B | $21.87B | $21.89B | $22.26B | $23.77B | $23.42B |
| Long-term debt | $7.25B | $4.38B | $6.58B | $6.13B | $5.33B | $5.38B | $6.57B | $7.98B | $7.24B | $6.55B | $5.72B | $6.97B | $5.65B | $43.39B | $48.34B | $39.60B | $35.06B | $36.65B | $47.60B | $42.85B |
| Shareholder equity | $9.99B | $10.56B | $12.24B | $14.84B | $15.71B | $15.96B | $13.62B | $15.15B | $14.85B | $14.27B | $16.18B | $11.74B | $14.03B | $51.60B | $37.82B | $35.95B | $31.06B | $29.43B | $16.34B | $18.47B |
| Retained earnings | $19.84B | $19.76B | $22.55B | $30.76B | $31.64B | $33.07B | $32.73B | $32.95B | $32.54B | $31.61B | $33.51B | $31.16B | $34.06B | $34.47B | $21.28B | $23.82B | $25.50B | $28.77B | $14.91B | $16.90B |
| Accounts receivable | $3.25B | $4.24B | $3.64B | $3.16B | $3.48B | $3.74B | $3.08B | $3.36B | $3.39B | $4.30B | $5.54B | $6.30B | $5.75B | $7.68B | $10.55B | $12.52B | $13.94B | $15.26B | $14.42B | $14.53B |
| Inventory | $2.08B | $2.16B | $1.76B | $1.41B | $1.20B | $1.38B | $1.66B | $1.50B | $1.56B | $1.22B | $1.24B | $1.17B | $1.20B | $4.29B | $2.07B | $2.10B | $2.34B | $2.66B | $2.56B | $2.69B |
| Goodwill | $4.83B | $5.00B | $4.83B | $5.22B | $5.23B | $5.59B | $7.63B | $7.10B | $7.03B | $6.88B | $6.88B | $6.86B | $6.54B | $22.49B | $20.55B | $20.50B | $21.15B | $21.17B | $21.72B | $21.75B |